{{cart_num}}
My CartCAS：151988-33-9
Molecular Formula：C141H210N32O44S1
Molecular Weight：3089.43
Purity：≥95%
Appearance：Lyophilized powder
Storage：Store at -20℃，2 years.(Avoid freeze/thaw cycles)
Qty：
Size：
| Product Type | Peptides |
| CAS | 151988-33-9 |
| Sequence(1LC) | Ac-AMVSEFLKQAWFIENEEQEYVQTVK |
| Sequence(3LC) | Ac-Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys |
| Molecular Formula | C141H210N32O44S1 |
| Molecular Weight | 3089.43 |
| Purity | ≥95% |
| Appearance | Lyophilized powder |
| Solubility | DMSO：20 mg/mL (adjust pH to 2 with HCl; H2O：5mg/mL (adjust pH to 10 with NaOH); *Ultrasonic solubilization; |
| Salt Form | Trifluoroacetate salt |
| Source | Synthetic |
| Storage | Store at -20℃，2 years.(Avoid freeze/thaw cycles) |
| Category/Label | Substrate and Enzyme Inhibitors |
| Background | Ac2-26， an active N-terminal peptide of annexin A1 (AnxA1)， attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression， inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue. |
| Reference | [1]. Liao WI， et al. Ac2-26， an Annexin A1 Peptide， Attenuates Ischemia-Reperfusion-Induced Acute Lung Injury. Int J Mol Sci. 2017 Aug 15;18(8). pii: E1771. |
| Unit | Bottle |
| Specification | 1mg 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
